PHC Holdings Corporation, a subsidiary of PHC Corporation and Cyfuse have entered into a fundamental agreement to form a strategic business alliance.
This partnership aims to leverage the expertise and technology of both companies to enhance their collaboration. By combining the strengths of PHC Corporation and Cyfuse, the alliance intends to generate novel benefits for patients and advanced medical settings. Furthermore, the collaboration seeks to foster the growth of the regenerative medicine and cell therapy sectors.
The strategic alliance between the two companies, will serve as the expansion of collective research and development endeavors, technological development, including Cyfuse's innovative regenerative medicine products, and create new products.
The collaboration between these two entities will leverage PHC's well-established traceability system from the evolution and manufacturing of their blood glucose measurement system. This integration aims to cultivate a production environment of utmost quality and efficiency.
By implementing robust management structures, the partnership will enable to establish a seamless production system for the purpose of effectively commercialising Cyfuse's pioneering regenerative medicine products.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!